Literature DB >> 314466

T suppressor (TG) lymphocytes fluctuate in parallel with changes in the clinical course of patients with multiple sclerosis.

J R Huddlestone, M B Oldstone.   

Abstract

Aberrant immune responses to several unrelated antigens observed in patients with multiple sclerosis have suggested faulty regulation of immunocompetent cells. Recently human T lymphocytes have been segregated into subpopulations. T lymphocytes that bear Fc receptors for IgG suppress B lymphocyte proliferation and the production of IgG. Here we report studies on the percentage of TG cells in the peripheral blood of 25 patients all of whom met stringent clinical criteria for the diagnosis of multiple sclerosis (MS). Many of these patients were followed for more than 14 months. In the total group, nine patients experienced definite acute exacerbations of disease followed by periods of remission. The mean percentages +/- 1 standard deviation of TG cells found in all MS patients during remission, 16 +/- 6 was significantly higher than the mean found in normal subjects, 12 +/- 2. In contrast, the mean found in patients experiencing an acute attack, 6 +/- 2 was significantly lower than the mean TG level of normal subjects. Moreover, when individual patients were followed through their clinical illness, levels of TG lymphocytes that were low during acute exacerbations invariably increased to relatively high levels with the onset of clinical remission.

Entities:  

Mesh:

Year:  1979        PMID: 314466

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2).

Authors:  G R Nemerow; R Wolfert; M E McNaughton; N R Cooper
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  T-lymphocyte subsets modifications in multiple sclerosis: correlation with clinical disease activity.

Authors:  M Prencipe; E Salerni; C D'Aurizio; C Marini; D Adorno; A M Berghella; P Pellegrini; F Papola; C U Casciani
Journal:  Ital J Neurol Sci       Date:  1986-12

3.  Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies.

Authors:  A J Thompson; J Brazil; E A Martin; M Hutchinson; C A Whelan; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-10       Impact factor: 10.154

Review 4.  Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.

Authors:  U Traugott
Journal:  Springer Semin Immunopathol       Date:  1985

Review 5.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

Review 6.  Immunoregulatory T cells in multiple sclerosis: markers and functions.

Authors:  M A Bach
Journal:  Springer Semin Immunopathol       Date:  1985

7.  The influence of disease activity on the number of blood cells of multiple sclerosis patients.

Authors:  U Patzold; U Wurster; K Mardt; M Schiemann
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

8.  Monoclonal antibody-defined immunoregulatory cells in multiple sclerosis cerebrospinal fluid.

Authors:  N Cashman; C Martin; J F Eizenbaum; J D Degos; M A Bach
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

9.  Monoclonal antibody analysis of blood T-cell subsets in multiple sclerosis.

Authors:  M Zaffaroni; D Caputo; A Ghezzi; S Marforio; C L Cazzullo
Journal:  Ital J Neurol Sci       Date:  1984-03

10.  The behaviour of OKT3-, OKT4- and OKT8-positive cells during phases of elevated spontaneous chemiluminescence activity (CL-A) in multiple sclerosis patients. A serial study.

Authors:  K P Hammann; R Röder; H C Hopf
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.